43 results on '"Yoshida, Nao"'
Search Results
2. Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia
3. A Nationwide Clinical Trial ALL-B12: An Optimized Therapy for Pediatric B-Precursor Acute Lymphoblastic Leukemia with Excellent Overall Survival and Minimal Non-Relapse Mortality: A Report from the Japan Children's Cancer Group
4. Outcomes of Hematopoietic Cell Transplantation for Patients with Refractory Cytopenia with Multilineage Dysplasia: A Comparison Children with Adolescents and Young Adults
5. Efficacy of OR21, a Novel Oral Demethylating Agent in Chronic Myeloid Leukemia
6. Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)
7. Hematopoietic Stem Cell Transplantation in Children with Refractory Acute Lymphoblastic Leukemia
8. Hematopoietic Cell Transplantation for Children with Acute Megakaryoblastic Leukemia without Down Syndrome
9. Hematopoietic Stem-Cell Transplantation in Children with Refractory Acute Myeloid Leukemia
10. Improved Outcome of Unrelated Cord Blood Transplantation in Children with Severe Aplastic Anemia
11. Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia
12. Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
13. Dexamethasone Palmitate for Engraftment Syndrome Is Associated with Favorable Transplant Outcome for Children with Hematological Malignancy
14. Genetic Background of Idiopathic Bone Marrow Failure Syndromes in Children
15. Clinical Significance of Natural Killer Cell-Mediated Alloreactivity in Unrelated Cord Blood Transplantation for Children with Acute Leukemia: A Japanese National Registry Study
16. The Efficacy of Low-Dose Cytosine Arabinoside Therapy for Patients of Down Syndrome with Transient Abnormal Myelopoiesis
17. Predicting Response to Immunosuppressive Therapy By the Combination of Minor Paroxysmal Nocturnal Hemoglobinuria Clones and Lymphocyte Telomere Length in Children with Aplastic Anemia
18. Outcomes of Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study
19. Identification Of Factors That Can Predict a Response To Intravenous Immunoglobulin Treatment In Children With Immune Thrombocytopenic Purpura
20. Clinical and Genetic Characterization Of Patients With C-CBL Mutated Juvenile Myelomonocytic Leukemia By Whole-Exome/Deep Sequencing
21. Aberrant DNA Methylation Is Associated With Poor Outcomes In Juvenile Myelomonocytic Leukemia
22. Genetic Events in Ikaros Gene Family (IKZF1 and IKZF2) in Pediatric T-Cell Lymphoblastic Leukemia/Lymphoma
23. Whole Exome Analysis Reveals Spectrum of Gene Mutations in Juvenile Myelomonocytic Leukemia
24. Donor-Type Aplasia After Bone Marrow Transplantation in Children with Aplastic Anemia: A Nationwide Retrospective Study
25. Risk Factors for Donor-Type Aplasia After Bone Marrow Transplant in Children with Acquired Bone Marrow Failure Syndrome
26. Outcomes of Hematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukemia with t(4;11)
27. Outcomes in Children with Severe Aplastic Anemia Receiving Bone Marrow Transplantation from an HLA-Matched Family Donor or Intensive Immunosuppressive Therapy As First-Line Treatment,
28. The Efficacy of Prophylactic Use of Antithrombin with Unfractionated Heparin or Danaparoid Sodium to Prevent Venous Thromboembolism In Children with Acute Lymphoblastic Leukemia
29. Second Stem Cell Transplantation for Relapse of Childhood Hematologic Malignancies Following Initial Transplantation.
30. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations
31. C-Cbl but Not TET2 Mutations Are Present in Patients with Juvenile Myelomonocytic Leukemia.
32. Predicting Response to Immunosuppressive Therapy in Childhood Aplastic Anemia.
33. Danapaloid Is Significantly Effective for the Prophylaxis of Hepatic Veno-Occlusive Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Cohort Study of 85 Children with Hematological Malignancies.
34. Correlation of Clinical Features with the Mutational Status of GM-CSF Signaling Pathway-Related Genes in Children with Juvenile Myelomonocytic Leukemia
35. JAK3, JAK2 and GATA1 Mutations in Childhood Acute Megakaryoblastic Leukemia with and without Down Syndrome.
36. Bone Marrow Transplantation from Alternative Donors in Children Receiving Rabbit ATG for Prophylaxis of Graft-Versus-Host Disease.
37. Correlation of Clinical Features with Mutational Status in Children with Juvenile Myelomonocytic Leukemia.
38. Presence of HLA-DR15, a Minor PNH Clone, or an Aplastic Anemia - Associated Autoantibody Do Not Predict a Favorable Response to Immunosuppressive Therapy in Children with Aplastic Anemia.
39. The JAK2 V617F Mutation Is Uncommon in Patients with Juvenile Myelomonocytic Leukemia.
40. Somatic mosaicism for oncogenic NRASmutations in juvenile myelomonocytic leukemia
41. Mutations of an E3 ubiquitin ligase c-Cblbut not TET2mutations are pathogenic in juvenile myelomonocytic leukemia
42. Clinical and Genetic Characterization Of Patients With C-CBLMutated Juvenile Myelomonocytic Leukemia By Whole-Exome/Deep Sequencing
43. Genetic Events in Ikaros Gene Family (IKZF1and IKZF2) in Pediatric T-Cell Lymphoblastic Leukemia/Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.